business
Forget Eli Lilly and Company: As June Volatility Rocks High-Flyers, This Stock Is a No-Brainer Buy
Key takeaways
- Eli Lilly s entire growth story rides two drugs while investors pay 41x trailing earnings, with realized prices already down 13% in Q1 2026.
- Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Pfizer didn t make the cut.
- Eli Lilly (NYSE:LLY) is the stock everyone wants to own right now, a $1.02 trillion obesity juggernaut that has ripped 20.9% higher in a single month on the back of the GLP-1 mania.
Forget Eli Lilly and Company: As June Volatility Rocks High-Flyers, This Stock Is a No-Brainer Buy Alex Sirois Fri, June 12, 2026 at 9:47 PM GMT+7 4 min read LLY PFE NVDA Quick Read Pfizer trades at 9x forward earnings, pays a 6.6% dividend backed by real free cash flow, and eleven directors simultaneously bought shares in April.
Eli Lilly s entire growth story rides two drugs while investors pay 41x trailing earnings, with realized prices already down 13% in Q1 2026.
Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Pfizer didn t make the cut. Grab the names FREE today.
Article preview — originally published by Yahoo Finance. Full story at the source.
Read full story on Yahoo Finance →
More top stories
Also covered by
Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop